Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-14

Clinical Trial Update: Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the effect of pregabalin on anxiety in patients with complex partial epilepsy; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Northeast Regional Epilepsy Group | Conditions: Epilepsy, Complex Partial | Phase 4 | Status: TERMINATED